TipRanks
Tianda Pharmaceuticals Ltd. (HK:0455)
:0455
Hong Kong Market
0455
Tianda Pharmaceuticals Ltd.
RESEARCH TOOLSreports
Want to see HK:0455 full AI Analyst Report?

Tianda Pharmaceuticals Ltd. (0455) Ratios

0 Followers

Tianda Pharmaceuticals Ltd. Ratios

HK:0455's free cash flow for Q4 2025 was HK$0.41. For the 2025 fiscal year, HK:0455's free cash flow was decreased by HK$ and operating cash flow was HK$-0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.83 0.83 0.86 1.10 1.54
Quick Ratio
 0.64 0.64 0.70 0.89 1.41
Cash Ratio
 0.27 0.27 0.34 0.52 0.94
Solvency Ratio
 -0.08 -0.14 -0.09 0.04 -0.01
Operating Cash Flow Ratio
 0.04 0.06 -0.04 -0.16 0.22
Short-Term Operating Cash Flow Coverage
 0.11 0.18 -0.08 -0.52 1.22
Net Current Asset Value
HK$ -93.80MHK$ -93.80MHK$ -43.48MHK$ 18.86MHK$ 123.95M
Leverage Ratios
Debt-to-Assets Ratio
 0.18 0.18 0.17 0.12 0.13
Debt-to-Equity Ratio
 0.29 0.29 0.25 0.19 0.22
Debt-to-Capital Ratio
 0.23 0.23 0.20 0.16 0.18
Long-Term Debt-to-Capital Ratio
 0.08 0.08 0.00 0.01 0.09
Financial Leverage Ratio
 1.64 1.64 1.51 1.55 1.73
Debt Service Coverage Ratio
 -0.10 -0.31 -0.44 0.16 -0.21
Interest Coverage Ratio
 0.00 0.00 -11.16 -5.87 -9.37
Debt to Market Cap
 0.51 0.45 0.34 0.22 0.15
Interest Debt Per Share
 0.06 0.06 0.06 0.06 0.07
Net Debt to EBITDA
 -9.80 -2.78 -0.84 -3.12 10.01
Profitability Margins
Gross Profit Margin
41.18%41.28%46.08%48.02%46.01%
EBIT Margin
-11.01%-16.75%-15.00%-3.90%-12.83%
EBITDA Margin
-3.72%-7.56%-15.00%2.94%-3.64%
Operating Profit Margin
-11.01%-16.75%-16.41%-5.45%-12.83%
Pretax Profit Margin
-19.00%-21.47%-16.47%-4.83%-11.68%
Net Profit Margin
-19.73%-21.67%-18.60%-4.54%-9.99%
Continuous Operations Profit Margin
-19.73%-21.75%-18.61%-4.70%-10.79%
Net Income Per EBT
103.84%100.96%112.94%94.01%85.56%
EBT Per EBIT
172.55%128.17%100.35%88.53%91.03%
Return on Assets (ROA)
-4.92%-9.36%-8.02%-2.63%-5.02%
Return on Equity (ROE)
-8.05%-15.33%-12.13%-4.08%-8.70%
Return on Capital Employed (ROCE)
-4.03%-10.62%-10.53%-4.81%-9.66%
Return on Invested Capital (ROIC)
-3.42%-9.07%-8.45%-4.00%-8.14%
Return on Tangible Assets
-6.13%-11.68%-9.99%-2.94%-5.54%
Earnings Yield
-14.49%-25.24%-16.89%-5.15%-6.27%
Efficiency Ratios
Receivables Turnover
 2.35 4.07 4.23 5.00 3.83
Payables Turnover
 1.38 2.39 2.64 2.34 4.14
Inventory Turnover
 2.45 4.24 4.42 4.25 6.12
Fixed Asset Turnover
 0.46 0.80 0.85 1.29 1.36
Asset Turnover
 0.25 0.43 0.43 0.58 0.50
Working Capital Turnover Ratio
 0.00 -8.52 -156.15 4.70 2.18
Cash Conversion Cycle
 40.10 23.02 30.52 3.23 66.73
Days of Sales Outstanding
 155.40 89.65 86.38 72.97 95.35
Days of Inventory Outstanding
 148.85 86.01 82.49 85.98 59.59
Days of Payables Outstanding
 264.14 152.64 138.35 155.73 88.22
Operating Cycle
 304.24 175.66 168.87 158.95 154.95
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 <0.01 >-0.01 -0.02 0.04
Free Cash Flow Per Share
 >-0.01 <0.01 -0.02 -0.05 0.03
CapEx Per Share
 <0.01 <0.01 0.02 0.03 0.01
Free Cash Flow to Operating Cash Flow
 -1.27 0.19 5.39 2.33 0.69
Dividend Paid and CapEx Coverage Ratio
 0.67 1.24 -0.20 -0.69 1.88
Capital Expenditure Coverage Ratio
 0.86 1.24 -0.23 -0.75 3.24
Operating Cash Flow Coverage Ratio
 0.07 0.11 -0.08 -0.44 0.56
Operating Cash Flow to Sales Ratio
 0.05 0.04 -0.03 -0.09 0.14
Free Cash Flow Yield
-4.97%1.01%-14.39%-24.76%6.29%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -6.90 -3.96 -5.92 -19.40 -15.94
Price-to-Sales (P/S) Ratio
 1.36 0.86 1.10 0.88 1.59
Price-to-Book (P/B) Ratio
 0.56 0.61 0.72 0.79 1.39
Price-to-Free Cash Flow (P/FCF) Ratio
 -20.13 99.20 -6.95 -4.04 15.91
Price-to-Operating Cash Flow Ratio
 25.52 19.23 -37.47 -9.42 11.01
Price-to-Earnings Growth (PEG) Ratio
 0.23 -0.28 -0.04 0.35 -0.11
Enterprise Value Multiple
 -46.44 -14.14 -8.19 26.81 -33.75
Enterprise Value
 321.55M 345.21M 405.11M 419.86M 671.54M
EV to EBITDA
 -46.44 -14.14 -8.19 26.81 -33.75
EV to Sales
 1.73 1.07 1.23 0.79 1.23
EV to Free Cash Flow
 -25.52 123.46 -7.75 -3.62 12.27
EV to Operating Cash Flow
 32.35 23.94 -41.77 -8.44 8.49
Tangible Book Value Per Share
 0.14 0.14 0.16 0.23 0.26
Shareholders’ Equity Per Share
 0.21 0.21 0.24 0.28 0.29
Tax and Other Ratios
Effective Tax Rate
 -0.04 -0.01 -0.13 0.03 0.08
Revenue Per Share
 0.09 0.15 0.15 0.25 0.25
Net Income Per Share
 -0.02 -0.03 -0.03 -0.01 -0.03
Tax Burden
 1.04 1.01 1.13 0.94 0.86
Interest Burden
 1.73 1.28 1.10 1.24 0.91
Research & Development to Revenue
 0.01 0.03 0.04 0.02 0.07
SG&A to Revenue
 0.51 0.55 0.58 0.16 0.15
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -0.14 -0.21 0.18 2.06 -1.45
Currency in HKD